期刊文献+

中国消化疾病患者对上消化道症状认知情况的多中心调研

The Self-understanding of Upper-gastrointestinal Symptoms in Chinese Patients with Digestive Disease:A Multicenter Questionnaire Survey
原文传递
导出
摘要 目的了解中国消化疾病患者对自身症状的认知情况,比较不同性别、学历、就诊次数的患者对症状的理解是否存在差异。方法中国医师协会联合武汉协和医院对全国9个省市具有消化道症状的患者进行随机上消化道症状理解情况的问卷调查。基本信息包括性别、年龄、学历、就诊次数。调查内容包括消化不良、餐后饱胀、烧心、早饱、上腹痛等5项症状。统计方法选用Mantel-Haenszel卡方检验。结果共发放问卷3 000份,收回有效问卷2 799份。对消化不良症状认识的正确率只有35.29%。对早饱症状认识的正确率为37.70%。对餐后饱胀症状认识的正确率为52.27%。对烧心症状认识的正确率仅为30.02%。30.02%的患者能够正确理解烧心的部位在胸骨后。对于上腹痛部位的认识正确率仅为25.4%。年龄越大的患者症状认知能力越低,学历越高的患者理解能力越高,首次复诊患者理解能力高于初诊和反复复诊患者。性别不是独立影响因素。结论病人对消化道症状的理解正确率较低,医师应在接诊时重新评估消化疾病患者的自述症状。 Objective To investigate the self-understanding abihiy of Chinese patients with digestive disease about the upper gastrointestinal symptoms. To evaluate the role of patients' characters, such as sex, age, education background and clinic visits, which might affect the understanding ability of patients. Methods A questionnaire was sent to 3 000 patients with diges- tive diseases. The 9-item questionnaite explored the basic patients characters and five major upper gastroenterology disorders. Results The response rate was 93.33% . Patients' understanding about the dyspepsia is poor( 35.29% ). The accuracy rate of early satiety and postprandial fullness is 37.7% and 52.27% separately they are the most confusing concepts mutually. The ac- curacy rate of heartburn is 30.02% ,the location of burning sensation is the key aspect for understanding of heartburn. The abili- ty of symptoms self-understanding in patients enhanced with increasing age, higher education background and clinic visits. Conclusion Based on the low accuracy rate of self-understanding of patients, this survey suggests that the gastroenterologists should reevaluated the symptoms of patients during the clinical inquiry.
出处 《临床消化病杂志》 2012年第5期259-261,共3页 Chinese Journal of Clinical Gastroenterology
关键词 消化道症状 认知情况 多中心调研 Upper- gastrointestinal symptoms Self- understanding Muhicenter questionnaire survey
  • 相关文献

参考文献8

  • 1TALLEY NJ. Functional gastrointestinal disorders in 2007 and Rome Ⅲ something new, something borrowed something objective [ J ]. Rev Gastroenterol Disord,2007,7 (2) :97.
  • 2KINOSHITA Y CHIBA T, FUTURE study group. Characteristics of Japanese patients with chronic gastritis and comparison with function- al dyspepsia defined by ROME Ⅲ criteria: based on the large- scale survey,FUTURE study[J]. Intern Med,2011,50(20) :2269.
  • 3DROSSMAN. DA, DUMITRASCU DL. Rome Ⅲ:New standard for functional gastrointestinal disorders [ J ]. J Gastrointestin Liver Dis, 2006,15(3) :237.
  • 4罗金燕.学习罗马Ⅲ标准,促进功能性胃肠病研究[J].中华消化杂志,2006,26(11):762-763. 被引量:17
  • 5赵卡冰,杨云生.罗马Ⅱ与罗马Ⅲ诊断标准的比较与体会[J].临床消化病杂志,2010,22(1):3-5. 被引量:21
  • 6STANGHELLINI V FRESOMI C. Editorial:Reflux, dyspepsia, and Rome Ⅲ [ J ]. Am J Gastroentero1,2010,105 (12) :2632.
  • 7JONES MP,COPPENS E,VOS R et al. A multidimensional model of psychobiological in teractions infunctional dyspepsia:a Structural e- quation modelling approach[J]. Gut,2012, PMID :22917658.
  • 8ANBARDAN SJ, DARVANI NE FERESHTEHNEJAD SM et al, Gen- derR01e in Irritable bowel syndrome: a comparison of Irritable bowel syndrome module( ROME Ⅲ) between male and female patients[ J ]. J Neuroga Stroenterol Motil,2012,18( 1 ) :70 .

二级参考文献13

  • 1LIN CHANG,MD.From Rome to Los Angeles-The Rome Ⅲ criteria functional gI Disorders.
  • 2THOMSON AB,BARKUN AN,ARMSTRONG D,et al.The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia:The canadian adult dyspepsia empiric treatment-prompt endoscopy(CADET-PE)[J].Aliment Pharmacol Ther,2003,17:1481.
  • 3A ERSRYD,I POSSERD,H ABRAHAMSSON.M.SIMREN subtyping the irritable bowel syndrome by predominant bowel habit:RomeⅡ versus Rome Ⅲ:Alimentary pharmacology and therapeutics.2007,26(6):953.
  • 4CAMILLERI M,CHEY WY,MAYER EA,et al.A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome[J].Arch Intern Med,2001,161:1733.
  • 5CHEY WD.Review article:tegaserod-the global experience[J].Ali-ment Pharmacol Ther,2004,20(Suppl 7):15.
  • 6MULLER-LISSNER SA,FUMAGALLI I,BARDHAN KD,et al.Tegaserod,a 5-HT4 receptor partial agonist,relieves symptoms in irritable bowel syndrome patients with abdominal pain,bloating and constipation[J].Aliment Pharmscol Ther,2001,15:1655.
  • 7Drossman DA.The functional gastrointestinal disorders and the Rome Ⅲ process.Gastroenterology,2006,130:1377-1390.
  • 8Van Oudenhove L,Joris V,Geeraerts B,et al.Determinants of symptom severity and weight loss in functional dyspepsia.Gastroenterology,2006,130 (4,suppl 2):A38.
  • 9Simren M,Strid H,Posserud I,et al.Additive effect of pathophysiological abnormalities on gastrointestinal symptoms in patients with irritable bowel syndrome.Gastroenterology,2006,130(4,suppl 2):A-510.
  • 10Tack J,Talley NJ,Camilleri M,et al.Functional gastroduodehal disorders.Gastroenterology,2006,130:1466-1479.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部